The world is radioactive and the inhabitants receive doses from natural as well as man-made sources. Exposure to ionizing radiation, even at low doses, carries health risks, of which the most important is of radiation-induced cancer later in life. The issue that has to be considered, therefore, is the acceptability of the risk. In this paper I discuss current estimates of radiation risk and the way in which the risk is managed in setting the standards of radiological protection.
THE RADIOACTIVE WORLD Figure 1 shows that 85% of the radiation dose received each year comes from natural sources while 15% on average comes from artificial sources, this being almost totally from medical exposures. The average individual dose in the UK is 2.6 millisievert (mSv) per annum, of which 2.2 mSv is from natural sources. Some of this radiation comes from outer space: high energy cosmic rays interact with the human body and give an annual dose around 0. 3 mSv. Human beings are exposed to y-rays emitted by the trace quantities of natural radioactive elements, such as uranium and thorium, in the ground and in building materials: the annual dose is about 0.4mSv. Food and drink also contain minute quantities of radioactive substances which are taken up by the tissues of the body and give an annual dose of 0.3 mSv. But the largest component of dose is from inhaled radon, which undergoes a series of radioactive decays in the lung with the emission of damaging alpha particles. On average, the annual dose from radon and its decay products is 1.3 mSv about half of the total dose from all natural sources of ionizing radiation.
Radon comes from the decay of an isotope of uranium which occurs in all earth materials. Being a gas, it can seep into houses and workplaces. It is the most variable of the sources of natural radiation, with doses ranging up to 100 times the national average. The National Radiological Protection Board (NRPB) has been identifying those areas of the country where homes are most affected by radon, and when indoor levels lead to doses above 10mSv per annum, provides advice on how to reduce them.
Exposure to cosmic radiation is increased at high altitudes where the shielding effect of the atmosphere is reduced. A frequent flyer who spends 100 h per annum in the air about four return flights to the west coast of the USA or a weekly shuttle between London and Glasgowwill increase his annual exposure by about 0.4mSv.
THE RISK
Essentially two types of radiation effects are observed in people exposed to radiation. The first, termed deterministic effects, occur when many cells in an organ or tissue are damaged or killed. The body has an ability to recover from such damage, but there will be a threshold above which so many cells are killed that the recovery mechanisms cannot cope; consequently, with increasing dose above this threshold, the severity of the effect will increase. Examples of these effects include failure of the bone marrow, which can lead to overwhelming infection or recurrent and persistent haemorrhage, and radiation burns of the skin. Such effects occur at relatively high doses of a few sieverts.
The second type of effect, termed stochastic, is related to the ability of ionizing radiation to damage DNA in human cells. Normally, such damage will be identified by the body's defences and the cells will be eliminated. There is, however, a small but finite probability that this type of damage, promoted by the influence of other agents apart from radiation, can lead to a malignant tumour. If this damage is to germ cells (sperm and ovum) there is the possibility of hereditary defects.
Before the Second World War, there were very limited data on stochastic effects and protection was therefore based on preventing deterministic effects, principally in the skin and primarily in workers occupationally exposed to radiation, such as radiologists. After the war, a wide range of artificial radionuclides became available, and occupational as well as public exposures became more widespread. By the 1950s, it was becoming apparent that there were excess cases of leukaemia among the survivors of Hiroshima and Nagasaki and the main concern in protection became to limit the probability of stochastic effects such as cancer. The severity of this effect is independent of the dose but the probability of its occurrence is proportional to the dose.
The 80000 or more survivors of the atomic bombs at Hiroshima and Nagasaki for whom there are good dose estimates now form the most comprehensive cohort from which the carcinogenic risks of radiation can be calculated. Compared with this group, most of the other exposed groups are small and often they received doses only to parts of the body. But the Japanese survivors received fairly high instantaneous doses; it is important therefore that epidemiologists at NRPB and in other countries should study the large groups of radiation workers who receive low radiation doses in a protracted fashion to see if the risks per unit dose are comparable. The findings so far suggest that they are. Interpretation of epidemiological studies and of experimental studies with animals at low doses is being influenced by accumulating information on the fundamental nature of the tumorigenic process. There is good evidence that the initiation process results from damage to DNA which leads to gene mutations in single target cells. Many argue that the critical damage is likely to be coincident damage to both DNA strands-DNA double-strand breaks. Although some double-strand damage will be repaired, completely errorfree repair, even at low doses, is unlikely.
There are 5000-10000 DNA damage events per hour per cell due to thermodynamic instability and attack by chemical radicals through endogenous biochemical reactions. In a typical DNA repair interval of about 4h, some 30000 events will occur. Because of this high level of single-strand DNA damage arising spontaneously in cells, it has been suggested that the small increment of damage induced by low-dose radiation will be insignificant for cancer risk. This argument is not sustainable since it fails to recognize the very low abundance of spontaneous DNA double-strand breaks and the critical importance of these lesions and their misrepair for cellular radiobiological response.
Some evidence exists that low-dose radiation induces or activates cellular DNA repair functions, the so-called adaptive response. Most such effects seen to date have been essentially short term, and the current consensus is that knowledge of their relevance to neoplastic processes is insufficiently developed and understood to influence present judgments on tumorigenic responses at low doses and low dose rates. At the level of DNA damage, consequently, there is no basis for assuming the existence of a dose threshold below which the risk of tumour induction would be zero. It is appropriate, therefore, to assume a progressive increase in risk with increasing dose1.
And so the objectives of radiation risk management in the latter part of this century have been to prevent deterministic risks and to restrict stochastic risks to acceptable levels. The notable exception is radiotherapy, where a deterministic effect is intentional.
Relying heavily on the data for Japanese survivors, the International Commission on Radiological Protection (ICRP) has quantified the lifetime risk of fatal cancer as a 5% increase, above the prevailing rate of 20-25%, for every sievert of radiation exposure in a population of all ages and both sexes. ICRP2 has also calculated the risk for serious hereditary disease at 1% per Sv: this is based on animal data but has so far not been confirmed in any human population.
A SYSTEM FOR PROTECTION
The primary aim of radiological protection is to provide an appropriate standard of protection for man without unduly limiting the beneficial practices giving rise to radiation exposure. This is achieved through a system with three basic components: * Justification Radiation exposures should be permitted only if they produce at least sufficient benefit to the exposed person or to society to offset the radiation risk. The principle of doing more good than harm. * Optimization Once justified, all reasonable steps should be taken to reduce doses to people as low as reasonably achievable, economic and social factors being taken into account. The principle ofmaximizing the margin ofgood over harm. * Limitation To ensure that the sum of doses or risks from all sources under control is below the recommended limits for individual persons. The principle of acceptable risk. Dose limits do not apply to medical exposures where it is the patient, not hospital workers or the general population, who will receive both the benefits and the detriments of the exposure.
Any type of practice that involves radiation exposure must be justified in advance of its use, but radiological protection may be only one part of a decision-making process that includes strategic and economic considerations.
ACCEPTABLE RISK
Determining acceptable levels of risk is central to the problem of setting dose limits for practices involving exposure to ionizing radiation. Most human activities carry some risk, and risks that are high are accepted by most people if they are perceived to be worthwhile. Other activities are not accepted because the risks are considered high in relation to the benefits even after attempts at risk reduction. In trying to establish an acceptable level of risk, one finds a difference in attitude towards voluntary as opposed to involuntary risks and between risks imposed on workers as opposed to the public at large. For radiation protection purposes, the relevant comparisons of risk are with those in normal occupational or private life in what one might judge to be a safe society. The issues for normal operations involving radiation are different from those in potential accidents involving radiation.
ICRP2 has found it useful to use three terms to indicate the degree of acceptability of a dose or risk. The first stark term is unacceptable, which indicates that the dose would not be acceptable on any reasonable basis in normal practice when the use of radiation is a matter of choice. Such doses might have to be accepted in abnormal conditions, as during a radiation accident. Doses that are not deemed unacceptable are then subdivided into those that are tolerable, meaning that they are not welcome but can reasonably be tolerated, and accepted, provided there is a pressure to ensure that protection is as good as it reasonably can be. Finally, there is some level of risk so low as to be regarded as trivial and not worth committing resources to reduce it further. All of this is shown in Figure 2 .
In this framework, a dose limit is set at the level of risk indicated by the boundary between tolerable and unacceptable and applied to the control of the total dose from all specified sources of radiation. The limit then protects the individual person from all the sources that are under control by ensuring that the total risk is tolerable. The concept of acceptable risk is not based on the ideas of professionals in radiological protection, but rather has to reflect the views of society and take note of legislative actions, judgments in the courts, or the outcome of public inquiries.
With this in mind, it is possible to look at numerical levels of risk that may correspond to each ICRP term. Considerations are different for workers and members of the public. For workers, the annual level of fatal risk that appears to be tolerated in industry around the world seems to be about one in 1000. ICRP has used this, with its risk per unit dose of fatal cancer, to establish the dose limit for workers at 20 mSv per annum.
For members of the public, the degree of acceptability is much more difficult to determine. A fatal risk of one in 1 000 000 per annum is commonly regarded as trivial. A widespread view seems to be that the maximum risk that can be imposed from a single source of fatality is around one in 100 000 per annum and that levels much beyond this verge on the unacceptable. ICRP has set the dose limit for the public at 1 mSv per annum, which represents a fatal risk of a few in 100 000 per annum. ICRP also took into account the existence of natural radiation which, without radon, gives an annual dose of about 1 mSv. This natural radiation may not be harmless, but it causes only a small detriment to health and can hardly be termed unacceptable.
MEDICAL EXPOSURES
The strategy for managing radiation risks in medicine is different from that required for occupational and environment exposures of the public. Doses Justification may be of a general nature for a procedure such as screening or insurance examinations, but in medicine there is also a need to justify doses to an individual patient in relation to a particular disease. Generic justification relates to a specified procedure, the aim being to judge whether the procedure will, in most cases, improve diagnosis or treatment: the breast screening programme is a topical example. Such judgments will be the responsibility of professional bodies, sometimes in conjunction with regulatory authorities. The Royal College of Radiologists has issued guidelines for doctors on best procedures3.
For exposures of individual patients, no further justification is required as long as the approved indications for the specified procedure are present. Because of the diversity of human disease, however, generic justification may not be sufficient in all circumstances. Individual justification, when required, is clearly the responsibility of the physician, who will take into account benefit and harm and the availability and efficacy of alternative non-ionizing technologies, the overall objective being the best management of the medical problem. Radiation doses and risks are small in most diagnostic examinations, but may be much larger for interventional radiology, where X rays are used to guide therapeutic procedures within the body. Risks are of a different order in radiotherapy, where normal tissue is unavoidably damaged during the killing of diseased tissues.
Optimization in diagnostic radiology means exposing the patient to the lowest dose consistent with the clinical purpose-that is, producing an image just good enough to make or exclude a diagnosis. There are, however, wide variations in doses for the same procedure even after account has been taken of the size and weight of patients. As an aid to optimization, the concept of reference doses has been introduced, and this has become part of the overall quality assurance or audit programme for X-ray procedures. A reference dose should trigger an internal investigation by a radiology department if the average dose for a specific examination is found to be above it. National reference doses for some common types of examinations were published by NRPB in 19904. They were empirically based on the 75th percentile doses for examinations observed in a limited survey of hospitals during the previous decade. Such doses are not meant to be construed as optimum levels, but there should be a clinical reason for exceeding them.
As indicated earlier, doses from most uses of ionizing radiation in diagnosis are low; they are also, in general, decreasing. But the growth in the number and usage of computed tomography (CT) X-ray machines causes some concern since doses are higher than in conventional film radiography-of the chest for example. Another cause for concern relates to some forms of interventional radiology where the doses to the skin can cause deterministic effects. And now that patients are receiving increasingly effective radiotherapy and surviving longer, there is some concern that second cancers from the irradiation of healthy tissue may become a serious problem later in life. NRPB has lately published a survey of conventional radiography procedures in 375 hospitals which shows that doses have decreased by an average of 30% during the last 10 years, mainly because of improvements in X-ray equipment: indeed, most hospitals are giving doses around half the national reference dosess. But the saving of dose in conventional radiography is probably outweighed by the increases in dose from CT. Although only 4% of investigations are with CT machines, they give 40% of the total dose received by all patients from diagnostic X-ray procedures in the UK.
THE EFFECT OF AGE
Age is an important factor in determining the risk from medical exposures because most exposures occur early or late in life rather than evenly throughout life. The risk of cancer after exposure decreases with increasing age, since there is a latent period, perhaps decades long, between exposure and manifestation. In technical language, the detriment from radiation is age-dependent. The implications for children are particularly important.
In conventional radiography, children mostly receive smaller doses than adult persons because of smaller physique and lower attenuation of the X rays in passing though the body, but current CT practice does not give the same savings. There may also be increased sensitivity to radiation in the very young, as the high incidence of thyroid cancers seen in the children of Chernobyl underlines. Conversely, risks to people of retirement age are a small fraction of the risks to young adults for the same dose.
NEW INFORMATION
The greatest opportunity for future insights lies in the revolution occurring in molecular genetics. This discipline should increase understanding of the mechanisms involved in the induction of cancer by ionizing radiation and assist in identifying those most vulnerable to injury from other environmental agents. Of particular relevance to the management of radiation risks is the question whether genetic susceptibility to spontaneously arising cancer signifies an increased risk from exposure to ionizing radiation. Current information on the heterogeneity of carcinogenic response, as the phenomenon is called, suggests that less than 1% of the population is likely to have increased susceptibility to radiation.
Exposed populations will contain susceptible persons, but the current wisdom is that their presence does not distort the general risk estimates. For those who are generally susceptible, however, the individual risk may be very high. This circumstance is particularly relevant to high dose procedures such as radiotherapy. Patients requiring radiotherapy may indeed include a proportion with cancer predisposing disorders, so that optimization of the dose regimen is likely to be most important.
Testing for susceptibility will present problems, but these will not be unique to radiology. There will be difficulties of high cost and limited availability, but improvements are occurring continually. There will moreover be fundamental ethical difficulties-the questionable benefit of testing if no treatment is available to correct the condition; the impairment of the quality of life for other family members who may carry the genetic defect; the possibility of discrimination in employment and insurance. These matters were recognized by Government when it established the Advisory Committee on Genetic Testing. CONCLUSION There are risks associated with exposure to ionizing radiation, and risk is deemed to be proportional to dose even down to low levels. It is first necessary to decide whether the risk should be run of exposing human beings to radiation in the circumstance of interest. It is also necessary to determine what degree of risk is acceptable for workers, general members of the public, and patients. In so doing, those who set the standards for radiological protection must reflect the views of society on the acceptability of risks in general. An especially important task for professional people is to apply the principle of optimization-that is, to maximize the margin of good over harm when using radiation. Clinical radiology exemplifies the need for informed management of doses to ensure that they are as low as reasonably achievable.
There is a continuing requirement to keep under review the scientific basis for the risk estimates and to exploit new insights so as to refine the values. But even if they do not change, the degree of risk that society is prepared to accept, voluntarily or involuntarily, may change. This in turn may require a review of the protection standards to maintain the best balance between the risks and benefits of ionizing radiation.
